{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:53:57Z","timestamp":1791082437109,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172368"],"award-info":[{"award-number":["82172368"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3401205"],"award-info":[{"award-number":["2022YFC3401205"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2705500"],"award-info":[{"award-number":["2023YFC2705500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.cca.2026.121347","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:43:08Z","timestamp":1789602188000},"page":"121347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Assay-dependent reclassification of biochemical hyperandrogenism in female androgen testing: CLIA versus LC-MS\/MS under common clinical decision thresholds"],"prefix":"10.1016","volume":"594","author":[{"given":"Xianhua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongsheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121347_bb0005","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 International evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121347_bb0010","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/cen.15265","article-title":"Society for endocrinology clinical practice guideline for the evaluation of androgen excess in women","volume":"103","author":"Elhassan","year":"2025","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cca.2026.121347_bb0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humupd\/dmae028","article-title":"Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: a systematic review and diagnostic meta-analysis to inform evidence-based guidelines","volume":"31","author":"Bizuneh","year":"2025","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.cca.2026.121347_bb0020","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","author":"O'Reilly","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121347_bb0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40618-024-02416-0","article-title":"Influence of state-of-the-art laboratory techniques on the phenotyping of women with polycystic ovary syndrome in the clinical setting","volume":"48","author":"Luque-Ramirez","year":"2025","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.cca.2026.121347_bb0030","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1210\/jc.2015-2807","article-title":"Implications of androgen assay accuracy in the phenotyping of women with polycystic ovary syndrome","volume":"101","author":"Tosi","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121347_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/rmb2.70013","article-title":"Total testosterone measured by liquid chromatograph-tandem mass spectrometry refines diagnosis of biochemical hyperandrogenism and better identifies subgroup at genuine risk of adverse fertility outcomes in women with polycystic ovary syndrome","volume":"25","author":"Li","year":"2026","journal-title":"Reprod. Med. Biol."},{"key":"10.1016\/j.cca.2026.121347_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cca.2022.11.025","volume":"538","author":"Zhang","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121347_bb0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/jcm10010119","article-title":"Hyperandrogenism by liquid chromatography tandem mass spectrometry in PCOS: focus on testosterone and androstenedione","volume":"10","author":"Grassi","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cca.2026.121347_bb0050","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1515\/cclm-2019-0959","article-title":"Development of a total serum testosterone, androstenedione, 17-hydroxyprogesterone, 11\u03b2-hydroxyandrostenedione and 11-ketotestosterone LC-MS\/MS assay and its application to evaluate pre-analytical sample stability","volume":"58","author":"Hawley","year":"2020","journal-title":"Clin. Chem. Lab. Med. Med"},{"key":"10.1016\/j.cca.2026.121347_bb0055","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1515\/cclm-2023-0847","article-title":"Evaluation of five multi-steroid LC\u2013MS\/MS methods used for routine clinical analysis: comparable performance was obtained for nine analytes","volume":"62","author":"Braun","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121347_bb0060","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1515\/cclm-2023-1138","article-title":"Report from the HarmoSter study: different LC-MS\/MS androstenedione, DHEAS and testosterone methods compare well; however, unifying calibration is a double-edged sword","volume":"62","author":"Fanelli","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121347_bb0065","article-title":"Age- and sex-adjusted reference intervals for steroid hormones measured by liquid chromatography\u2013tandem mass spectrometry using a widely available kit","volume":"13","author":"Kunz","year":"2024","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.cca.2026.121347_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119852","article-title":"Sex- and age-specific reference intervals of 16 steroid metabolites quantified simultaneously by LC-MS\/MS in sera from 2458 healthy subjects aged 0 to 77 years","volume":"562","author":"Frederiksen","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121347_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117440","article-title":"Association of classic and 11-oxygenated androgens with polycystic ovaries and menstrual cycle prolongation in infertile women with PCOS","volume":"547","author":"Ma","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121347_bb0080","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1093\/ejendo\/lvad047","article-title":"The clinical and biochemical significance of 11-oxygenated androgens in human health and disease","volume":"188","author":"Storbeck","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2026.121347_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.70022","article-title":"Exploring the predictive role of 11-oxyandrogens in diagnosing polycystic ovary syndrome","volume":"8","author":"Mody","year":"2025","journal-title":"Endocrinol. Diabetes Metab."},{"key":"10.1016\/j.cca.2026.121347_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.talo.2025.100459","article-title":"Simultaneous profiling of classic and 11-oxygenated androgens via a novel derivatization method coupled with HPLC-MS\/MS: a game-changer for endocrine disorders","volume":"11","author":"Zhang","year":"2025","journal-title":"Talanta Open"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126005292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126005292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:32:38Z","timestamp":1791081158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126005292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":18,"alternative-id":["S0009898126005292"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121347","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assay-dependent reclassification of biochemical hyperandrogenism in female androgen testing: CLIA versus LC-MS\/MS under common clinical decision thresholds","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121347"}}